Ellington Management Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ellington Management Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,200	Closed	-$245K	–	826
2019 Q4	$245K	Buy	+2,200	New	+$226K	0.05%	375
2019 Q2	–	Sell	-2,400	Closed	-$265K	–	854
2019 Q1	$265K	Buy	+2,400	New	+$251K	0.05%	403
2017 Q4	–	Sell	-8,600	Closed	-$655K	–	883
2017 Q3	$655K	Sell	8,600 -700	-8%	-$52.9K	0.11%	144
2017 Q2	$698K	Buy	9,300 +4,200	+82%	+$291K	0.1%	156
2017 Q1	$333K	Buy	+5,100	New	+$300K	0.01%	432
2016 Q2	–	Sell	-9,600	Closed	-$410K	–	549
2016 Q1	$410K	Buy	+9,600	New	+$406K	0.18%	162
2015 Q3	–	Sell	-6,000	Closed	-$218K	–	964
2015 Q2	$218K	Buy	+6,000	New	+$190K	0.05%	565

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Ellington Management Group's PRAH Position: Q1 2020 in Review

Ellington Management Group sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 2,200 shares — an estimated $245K sold.

Ellington Management Group first reported a position in PRAH in Q2 2015 and held it in 7 quarters. The position peaked at $698K in Q2 2017. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

Ellington Management Group reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
Ellington Management Group sold 2,200 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $245K.
Ellington Management Group first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 7 quarters.
Ellington Management Group's PRA Health Sciences, Inc. position peaked at $698K in Q2 2017.
301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.